The inspection, conducted between August 11-13, 2025, was a pre-approval inspection for three products and also covered general current Good Manufacturing Practices (cGMP). Shares of Zydus Lifesciences Ltd ended at ₹989.05, up by ₹32.95 or 3.45%, on the BSE today (August 13).
